BR0110954A - Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori - Google Patents

Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori

Info

Publication number
BR0110954A
BR0110954A BR0110954-5A BR0110954A BR0110954A BR 0110954 A BR0110954 A BR 0110954A BR 0110954 A BR0110954 A BR 0110954A BR 0110954 A BR0110954 A BR 0110954A
Authority
BR
Brazil
Prior art keywords
pylori infection
pharmaceutical preparation
helicobacter pylori
preparation
infection
Prior art date
Application number
BR0110954-5A
Other languages
English (en)
Inventor
Kyoko Tsuchiya
Akio Okamura
Junichi Kawasaki
Shinichiro Uno
Atsunari Noda
Satoshi Nishiwaki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26592228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0110954(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR0110954A publication Critical patent/BR0110954A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Atmospheric Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PREPARAçãO FARMACêUTICA PARA DIAGNóSTICO DE INFECçãO POR HELICOBACTER PYLORI". A presente invenção refere-se a uma preparação revestida para a detecção de uma infecção por H. pylori de acordo com um protocolo de teste de sopro de uréia que compreende uma composição de núcleo contendo pelo menos uma uréia rotulada com isótopo de C, um excipiente e um lubrificante em proporções definidas e revestida com 0,1-10 partes em peso de um agente de revestimento com base em 100 partes em peso da composição de núcleo. Com esta preparação, a influência das bactérias produtoras de urease residentes em órgãos que não o estómago, tais como a boca e a garganta, é excluída para permitir um diagnóstico de infecção por H. pylori sem o risco de um teste falso-positivo e com rapidez razoável.
BR0110954-5A 2000-05-19 2001-05-17 Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori BR0110954A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000148150 2000-05-19
JP2000259845 2000-08-29
PCT/JP2001/004122 WO2001087353A1 (fr) 2000-05-19 2001-05-17 Preparation servant a diagnostiquer les infections par l'$m(f)i$m(g)helicobacter pylori$m(f)/i$m(g)

Publications (1)

Publication Number Publication Date
BR0110954A true BR0110954A (pt) 2005-01-11

Family

ID=26592228

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110954-5A BR0110954A (pt) 2000-05-19 2001-05-17 Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori

Country Status (12)

Country Link
EP (1) EP1283060B1 (pt)
JP (1) JP4683812B2 (pt)
KR (1) KR100774014B1 (pt)
CN (1) CN1263516C (pt)
AU (2) AU2001256768B2 (pt)
BR (1) BR0110954A (pt)
CA (1) CA2408992C (pt)
DE (1) DE60143196D1 (pt)
MX (1) MXPA02011424A (pt)
PT (1) PT1283060E (pt)
TW (1) TWI296530B (pt)
WO (1) WO2001087353A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60122939T2 (de) 2000-12-21 2007-01-11 Nitromed, Inc., Bedford Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
US20080146956A1 (en) * 2006-12-17 2008-06-19 Campuzano German A Method based on a breath test for the detection of pathogen microorganisms
CN101231284B (zh) * 2007-01-23 2012-09-26 深圳市先亚生物科技有限公司 诊断幽门螺杆菌感染的尿素试剂盒
ITMI20121462A1 (it) * 2012-08-31 2014-03-01 Francesco Maria Bulletti Preparato a rilascio vaginale per la diagnosi della pervietà e della funzione utero tubarica femminile umana finalizzata alla fecondazione dei gameti
CN106620736A (zh) * 2016-11-09 2017-05-10 北京勃然制药有限公司 一种新型尿素[13c]检测药剂
KR102637908B1 (ko) 2018-12-28 2024-02-20 씨제이제일제당 (주) 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06157317A (ja) * 1992-11-19 1994-06-03 Nisshin Flour Milling Co Ltd 消化性潰瘍治療剤
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
JP2768559B2 (ja) * 1994-11-02 1998-06-25 ダイアバクト・エイ・ビー ヘリコバクテル・ピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒ Ｐｙｌｏｒｉ）の検出のための診断用調剤
JP3963982B2 (ja) * 1995-08-02 2007-08-22 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
TW438608B (en) * 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
EP0860170B1 (en) * 1996-08-13 2000-03-22 Kyowa Hakko Kogyo Co., Ltd. Tablets based on isotope-labeled urea
EP0960170A1 (en) * 1997-01-31 1999-12-01 Elisha Technologies Co. L.L.C. Corrosion protective coatings
MX9703918A (es) * 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.

Also Published As

Publication number Publication date
WO2001087353A1 (fr) 2001-11-22
TWI296530B (en) 2008-05-11
DE60143196D1 (de) 2010-11-18
HK1063741A1 (en) 2005-01-14
PT1283060E (pt) 2010-11-22
JPWO2001087353A1 (ja) 2004-04-30
KR100774014B1 (ko) 2007-11-08
EP1283060B1 (en) 2010-10-06
JP4683812B2 (ja) 2011-05-18
CA2408992C (en) 2010-03-23
KR20030001506A (ko) 2003-01-06
CN1489478A (zh) 2004-04-14
AU2001256768B2 (en) 2006-03-02
EP1283060A1 (en) 2003-02-12
MXPA02011424A (es) 2003-04-25
EP1283060A4 (en) 2006-03-22
AU5676801A (en) 2001-11-26
CA2408992A1 (en) 2002-11-18
CN1263516C (zh) 2006-07-12

Similar Documents

Publication Publication Date Title
Bradley et al. Group C streptococcal bacteremia: analysis of 88 cases
Marrie Coxiella burnetii (Q fever) pneumonia
Roberts Fusobacterial infections: an underestimated threat
Bayindir et al. Nitric oxide concentrations in saliva and dental plaque in relation to caries experience and oral hygiene
BR9809550A (pt) Artigo para higiene dental e processos para manufaturar um artigo para higiene dental, para friccionar uma região interdental de um mamìfero e para gerar um agente ativo na boca.
BR0110954A (pt) Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori
DE69531613D1 (de) Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden
TR200400363T4 (tr) Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı
Snyders et al. Oral chlorhexidine in the prevention of ventilator-associated pneumonia in critically ill adults in the ICU: a systematic review
BRPI0518328A2 (pt) agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica
BR0209562A (pt) Molécula de conjugado imunogênico, composição farmacêutica, método para preparar uma molécula de conjugado de polipeptìdeo-ácido hialurÈnico de baixo peso molecular, anticorpo purificado, métodos para eliciar uma resposta anticorpo em um mamìfero, e para inibir infecção estreptocócica em um mamìfero e a progressão de infecção em um mamìfero por bactérias contendo ha, e, kit de imunoensaio diagnóstico
Bianchini et al. A model of mandibular movements during speech: normative pilot study for the Brazilian Portuguese language
SE8903625D0 (sv) Antibacterial composition
Bergogue-Bèrézin Predicting the efficacy of antimicrobial agents in respiratory infections—is tissue concentration a valid measure?
Dunn et al. Ammonia vapour in the mouth as a diagnostic marker for Helicobacter pylori infection: preliminary'proof of principle'pharmacological investigations
ATE219689T1 (de) Diagnostische zusammensetzung
BR9914945A (pt) Processo para proporcionar terapiacosmética/medicinal
BR9811422A (pt) Processo para a inibição de hiperplasia celular de músculo liso vascular em um paciente humano ou em outro paciente animal de sangue quente necessitando de tal tratamento, uso de pelo menos um oligossacarìdeo sulfatado, e, composição farmacêutica ou veterinária para a inibição de hiperplasia celular de músculo liso vascular
Luey et al. Vaccine coverage of Streptococcus pneumoniae in Hong Kong with attention to the multiple-antibiotic-resistant strains
Fik et al. The Composition of the Microbiotes of the Neck Part of the Teeth in the Area of the Gum Edge of Rats at the End of the Second, Fourth and Sixth Weeks of Opioid Influence
Moreno et al. Tratamento da periodontite agressiva e alterações nos compostos sulfurados voláteis
Yaegaki et al. The effect of mouthwash on oral malodour production
Davidovic-Plavsic et al. Urinary activities of proximal tubule enzymes in neonates treated with gentamicin
Gunnison et al. Tissue distribution of S-sulfonate metabolites following exposure to sulfur dioxide
Zahid et al. THE INFLUENCE OF MOISTURE ON THE SETTING TIME OF THE LATEST COMMERCIALLY AVAILABLE CALCIUM HYDROXIDE CEMENTS; A CLEAR GUIDELINE FOR THE DENTIST.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 51/04, 9/30, 47/02, 47/10, 47/14, 47/26, 47/32, 47/36, 47/38; A61P 31/00

Ipc: A61K 51/04 (2011.01), A61K 9/30 (2011.01), A61K 47

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time